BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ruiz-Calvo A, Maroto IB, Bajo-Grañeras R, Chiarlone A, Gaudioso Á, Ferrero JJ, Resel E, Sánchez-Prieto J, Rodríguez-Navarro JA, Marsicano G, Galve-Roperh I, Bellocchio L, Guzmán M. Pathway-Specific Control of Striatal Neuron Vulnerability by Corticostriatal Cannabinoid CB1 Receptors. Cereb Cortex 2018;28:307-22. [PMID: 29121220 DOI: 10.1093/cercor/bhx285] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Shang H, Li P, Lin X, Cai Q, Li Z, Deng L, Song Y, Chen JF, Zhou J. Neuronal and astrocytic CB1R signaling differentially modulates goal-directed behavior and working memory by distinct temporal mechanisms. Neuropsychopharmacology 2023. [PMID: 36694040 DOI: 10.1038/s41386-023-01533-3] [Reference Citation Analysis]
2 Barbato G, Nisticò R, Triaca V. Exploiting Focused Ultrasound to Aid Intranasal Drug Delivery for Brain Therapy. Front Pharmacol 2022;13:786475. [DOI: 10.3389/fphar.2022.786475] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Burgaz S, García C, Gonzalo-Consuegra C, Gómez-Almería M, Ruiz-Pino F, Unciti JD, Gómez-Cañas M, Alcalde J, Morales P, Jagerovic N, Rodríguez-Cueto C, de Lago E, Muñoz E, Fernández-Ruiz J. Preclinical Investigation in Neuroprotective Effects of the GPR55 Ligand VCE-006.1 in Experimental Models of Parkinson's Disease and Amyotrophic Lateral Sclerosis. Molecules 2021;26:7643. [PMID: 34946726 DOI: 10.3390/molecules26247643] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
4 Gómez-Almería M, Burgaz S, Costas-Insua C, Rodríguez-Cueto C, Santos-García I, Rodríguez-Crespo I, García C, Guzmán M, de Lago E, Fernández-Ruiz J. BiP Heterozigosity Aggravates Pathological Deterioration in Experimental Amyotrophic Lateral Sclerosis. Int J Mol Sci 2021;22:12533. [PMID: 34830414 DOI: 10.3390/ijms222212533] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Goldstein Ferber S, Weller A, Yadid G, Friedman A. Discovering the Lost Reward: Critical Locations for Endocannabinoid Modulation of the Cortico-Striatal Loop That Are Implicated in Major Depression. Int J Mol Sci 2021;22:1867. [PMID: 33668515 DOI: 10.3390/ijms22041867] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Beiersdorf J, Hevesi Z, Calvigioni D, Pyszkowski J, Romanov R, Szodorai E, Lubec G, Shirran S, Botting CH, Kasper S, Guy GW, Gray R, Di Marzo V, Harkany T, Keimpema E. Adverse effects of Δ9-tetrahydrocannabinol on neuronal bioenergetics during postnatal development. JCI Insight 2020;5:135418. [PMID: 33141759 DOI: 10.1172/jci.insight.135418] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
7 Zhao Z, Soria-gómez E, Varilh M, Covelo A, Julio-kalajzić F, Cannich A, Castiglione A, Vanhoutte L, Duveau A, Zizzari P, Beyeler A, Cota D, Bellocchio L, Busquets-garcia A, Marsicano G. A Novel Cortical Mechanism for Top-Down Control of Water Intake. Current Biology 2020;30:4789-4798.e4. [DOI: 10.1016/j.cub.2020.09.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
8 Blázquez C, Ruiz-Calvo A, Bajo-Grañeras R, Baufreton JM, Resel E, Varilh M, Pagano Zottola AC, Mariani Y, Cannich A, Rodríguez-Navarro JA, Marsicano G, Galve-Roperh I, Bellocchio L, Guzmán M. Inhibition of striatonigral autophagy as a link between cannabinoid intoxication and impairment of motor coordination. Elife 2020;9:e56811. [PMID: 32773031 DOI: 10.7554/eLife.56811] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
9 Blumenstock S, Dudanova I. Cortical and Striatal Circuits in Huntington's Disease. Front Neurosci 2020;14:82. [PMID: 32116525 DOI: 10.3389/fnins.2020.00082] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 11.0] [Reference Citation Analysis]
10 Cristino L, Bisogno T, Di Marzo V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat Rev Neurol 2020;16:9-29. [DOI: 10.1038/s41582-019-0284-z] [Cited by in Crossref: 302] [Cited by in F6Publishing: 320] [Article Influence: 75.5] [Reference Citation Analysis]
11 Zhang Z, Wei S, Du H, Su Z, Wen Y, Shang Z, Song X, Xu Z, You Y, Yang Z. Zfhx3 is required for the differentiation of late born D1-type medium spiny neurons. Experimental Neurology 2019;322:113055. [DOI: 10.1016/j.expneurol.2019.113055] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
12 Loonen AJ, Wilffert B, Ivanova SA. Putative role of pharmacogenetics to elucidate the mechanism of tardive dyskinesia in schizophrenia. Pharmacogenomics 2019;20:1199-223. [PMID: 31686592 DOI: 10.2217/pgs-2019-0100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
13 Zhu Y, Liu B, Zheng X, Wu J, Chen S, Chen Z, Chen T, Huang Z, Lei W. Partial decortication ameliorates dopamine depletion‑induced striatal neuron lesions in rats. Int J Mol Med 2019;44:1414-24. [PMID: 31364729 DOI: 10.3892/ijmm.2019.4288] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Smith‐dijak AI, Sepers MD, Raymond LA. Alterations in synaptic function and plasticity in Huntington disease. J Neurochem 2019;150:346-65. [DOI: 10.1111/jnc.14723] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 15.3] [Reference Citation Analysis]
15 Ruiz-Calvo A, Bajo-Grañeras R, Maroto IB, Zian D, Grabner GF, García-Taboada E, Resel E, Zechner R, Zimmermann R, Ortega-Gutiérrez S, Galve-Roperh I, Bellocchio L, Guzmán M. Astroglial monoacylglycerol lipase controls mutant huntingtin-induced damage of striatal neurons. Neuropharmacology 2019;150:134-44. [PMID: 30914306 DOI: 10.1016/j.neuropharm.2019.03.027] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
16 Aguareles J, Paraíso-Luna J, Palomares B, Bajo-Grañeras R, Navarrete C, Ruiz-Calvo A, García-Rincón D, García-Taboada E, Guzmán M, Muñoz E, Galve-Roperh I. Oral administration of the cannabigerol derivative VCE-003.2 promotes subventricular zone neurogenesis and protects against mutant huntingtin-induced neurodegeneration. Transl Neurodegener 2019;8:9. [PMID: 30899454 DOI: 10.1186/s40035-019-0148-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
17 Reiner A, Deng YP. Disrupted striatal neuron inputs and outputs in Huntington's disease. CNS Neurosci Ther 2018;24:250-80. [PMID: 29582587 DOI: 10.1111/cns.12844] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 9.2] [Reference Citation Analysis]
18 Aymerich MS, Aso E, Abellanas MA, Tolon RM, Ramos JA, Ferrer I, Romero J, Fernández-Ruiz J. Cannabinoid pharmacology/therapeutics in chronic degenerative disorders affecting the central nervous system. Biochem Pharmacol 2018;157:67-84. [PMID: 30121249 DOI: 10.1016/j.bcp.2018.08.016] [Cited by in Crossref: 59] [Cited by in F6Publishing: 62] [Article Influence: 11.8] [Reference Citation Analysis]
19 Garcia-Arencibia M, Molina-Holgado E, Molina-Holgado F. Effect of endocannabinoid signalling on cell fate: life, death, differentiation and proliferation of brain cells. Br J Pharmacol 2019;176:1361-9. [PMID: 29797438 DOI: 10.1111/bph.14369] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]